GlassScriptPhysician profile
Angela Tsai-Robson
NPI 1598781148
$3,802.51
in general payments reported to CMS, 2019-2025
30 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $314 · 2021: $801 · 2022: $925 · 2023: $540 · 2024: $543 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Debt Forgiveness: $100 · Long Term Medical Supply Or Device Loan: $34.98 · Entertainment: $27.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.37 |
| Debt Forgiveness | $100.19 |
| Long Term Medical Supply Or Device Loan | $34.98 |
| Entertainment | $27.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $819.46 | 2021-2025 | Acthar |
| Alcon Vision LLC | $567.11 | 2019-2025 | Precision 1, Total30 |
| Sun Pharmaceutical Industries INC. | $287.47 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $262.20 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $219.04 | 2019-2025 | Acuvue |
| Kala Pharmaceuticals, INC. | $188.76 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $176.27 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Coopervision INC. | $165.42 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Maculogix, INC. | $160.65 | 2020-2021 | |
| Baxter Healthcare | $135.17 | 2023 | Hillrom - Cp 150 Resting Electrocardiograph |
| Tarsus Pharmaceuticals, INC. | $101.90 | 2024-2025 | Xdemvy |
| Abbvie INC. | $93.55 | 2022-2024 | |
| Notal Vision, INC. | $76.32 | 2019 | |
| Sight Sciences, INC. | $72.46 | 2019-2024 | Tearcare System |
| Optos, INC. | $70.14 | 2020-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $62.16 | 2019-2022 | |
| Thea Pharma INC. | $46.11 | 2023-2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $41.41 | 2023 | |
| Shire North American Group INC | $30.64 | 2019 | |
| Lombart Brothers, INC. | $29.20 | 2022 | |
| Tearlab Corp | $29.04 | 2021 | |
| Allergan, INC. | $26.25 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $24.38 | 2020 | |
| Dompe US, INC. | $24.21 | 2025 | Oxervate |
| Visioneering Technologies, INC. | $19.54 | 2019 | |
| Eyevance Pharmaceuticals LLC | $17.92 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Oyster Point Pharma, INC. | $14.40 | 2022 | |
| Topcon Healthcare, INC. | $13.68 | 2020 | |
| Oasis Medical, INC. | $10.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Tsai-Robson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.